Freeline Therapeutics Holdings plc Quarterly Liabilities and Equity in USD from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Freeline Therapeutics Holdings plc quarterly Liabilities and Equity history and growth rate from Q4 2019 to Q3 2023.
  • Freeline Therapeutics Holdings plc Liabilities and Equity for the quarter ending September 30, 2023 was $49.2M, a 50.8% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $49.2M -$50.9M -50.8% Sep 30, 2023 6-K 2023-12-01
Q2 2023 $62.7M -$99.5M -61.4% Jun 30, 2023 6-K 2023-08-15
Q1 2023 $81.4M -$115M -58.5% Mar 31, 2023 6-K 2023-05-30
Q4 2022 $86.6M -$54.5M -38.6% Dec 31, 2022 6-K 2023-12-01
Q3 2022 $100M -$70.7M -41.4% Sep 30, 2022 6-K 2022-11-15
Q2 2022 $162M -$38.9M -19.4% Jun 30, 2022 6-K 2022-08-09
Q1 2022 $196M -$39.1M -16.6% Mar 31, 2022 6-K 2022-05-10
Q4 2021 $141M -$127M -47.5% Dec 31, 2021 20-F 2023-04-04
Q3 2021 $171M Sep 30, 2021 6-K 2021-11-09
Q2 2021 $201M +$60.6M +43.1% Jun 30, 2021 6-K 2021-08-16
Q1 2021 $235M Mar 31, 2021 6-K 2021-05-17
Q4 2020 $269M +$171M +176% Dec 31, 2020 20-F 2022-03-31
Q2 2020 $140M Jun 30, 2020 6-K 2020-10-29
Q4 2019 $97.4M Dec 31, 2019 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.